ImmuCell Corporation Acquisitions, Net of Cash Acquired
ImmuCell Corporation (ICCC) reported Acquisitions, Net of Cash Acquired of $532.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2020-03-27
- ImmuCell Corporation payments to acquire businesses, net of cash acquired for the quarter ending 2016-12-31 was $0.00.
- ImmuCell Corporation payments to acquire businesses, net of cash acquired for the quarter ending 2016-09-30 was $0.00.
- ImmuCell Corporation payments to acquire businesses, net of cash acquired for fiscal 2016 was $532.00K.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 0 month | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $0.00 derived: sum of 2 quarters · filed 2017-03-30 | $532.00K 10-K · filed 2017-03-30 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $532.00K 10-Q · filed 2016-11-10 | |||
| 2016-06-30 | $532.00K 10-Q · filed 2016-08-11 | ||||
| 2016-01-04 | $534.00K 10-Q · filed 2016-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |